Cargando…
The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
BACKGROUND: Recent reports using metabolism regulating drugs showed that nutrient deprivation was an efficient tool to suppress cancer progression. In addition, autophagy control is emerging to prevent cancer cell survival. Autophagy breaks down the unnecessary cytoplasmic components into anabolic u...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562121/ https://www.ncbi.nlm.nih.gov/pubmed/26345371 http://dx.doi.org/10.1186/s12885-015-1640-z |
_version_ | 1782389117533814784 |
---|---|
author | Jeon, Jeong Yong Kim, Seung Won Park, Ki Cheong Yun, Mijin |
author_facet | Jeon, Jeong Yong Kim, Seung Won Park, Ki Cheong Yun, Mijin |
author_sort | Jeon, Jeong Yong |
collection | PubMed |
description | BACKGROUND: Recent reports using metabolism regulating drugs showed that nutrient deprivation was an efficient tool to suppress cancer progression. In addition, autophagy control is emerging to prevent cancer cell survival. Autophagy breaks down the unnecessary cytoplasmic components into anabolic units and energy sources, which are the most important sources for making the ATP that maintains homeostasis in cancer cell growth and survival. Therefore, the glucose analog 2-deoxyglucose (2DG) has been used as an anticancer reagent due to its inhibition of glycolysis. METHODS: Prostate cancer cells (PC3) were treated with 2DG for 6 h or 48 h to analyze the changing of cell cycle and autophagic flux. Rapamycin and LC3B overexpressing vectors were administered to PC3 cells for autophagy induction and chloroquine and shBeclin1 plasmid were used to inhibit autophagy in PC3 cells to analyze PC3 cells growth and survival. The samples for western blotting were prepared in each culture condition to confirm the expression level of autophagy related and regulating proteins. RESULTS: We demonstrated that 2DG inhibits PC3 cells growth and had discriminating effects on autophagy regulation based on the different time period of 2DG treatment to control cell survival. Short-term treatment of 2DG induced autophagic flux, which increased microtubule associated protein 1 light chain 3B (LC3B) conversion rates and reduced p62 levels. However, 2DG induced autophagic flux is remarkably reduced over an extended time period of 2DG treatment for 48 h despite autophagy inducing internal signaling being maintained. The relationship between cell growth and autophagy was proved. Increased autophagic flux by rapamycin or LC3B overexpression powerfully reduced cell growth, while autophagy inhibition with shBeclin1 plasmid or chloroquine had no significant effect on regulating cell growth. CONCLUSION: Given these results, maintaining increased autophagic flux was more effective at inhibiting cancer cell progression than inhibition of autophagic flux, which is necessary for the survival of PC3 cells. Autophagic flux should be tightly regulated to maintain metabolic homeostasis for cancer cell growth and survival in PC3 cells and is a suitable target for cancer therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1640-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4562121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45621212015-09-09 The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells Jeon, Jeong Yong Kim, Seung Won Park, Ki Cheong Yun, Mijin BMC Cancer Research Article BACKGROUND: Recent reports using metabolism regulating drugs showed that nutrient deprivation was an efficient tool to suppress cancer progression. In addition, autophagy control is emerging to prevent cancer cell survival. Autophagy breaks down the unnecessary cytoplasmic components into anabolic units and energy sources, which are the most important sources for making the ATP that maintains homeostasis in cancer cell growth and survival. Therefore, the glucose analog 2-deoxyglucose (2DG) has been used as an anticancer reagent due to its inhibition of glycolysis. METHODS: Prostate cancer cells (PC3) were treated with 2DG for 6 h or 48 h to analyze the changing of cell cycle and autophagic flux. Rapamycin and LC3B overexpressing vectors were administered to PC3 cells for autophagy induction and chloroquine and shBeclin1 plasmid were used to inhibit autophagy in PC3 cells to analyze PC3 cells growth and survival. The samples for western blotting were prepared in each culture condition to confirm the expression level of autophagy related and regulating proteins. RESULTS: We demonstrated that 2DG inhibits PC3 cells growth and had discriminating effects on autophagy regulation based on the different time period of 2DG treatment to control cell survival. Short-term treatment of 2DG induced autophagic flux, which increased microtubule associated protein 1 light chain 3B (LC3B) conversion rates and reduced p62 levels. However, 2DG induced autophagic flux is remarkably reduced over an extended time period of 2DG treatment for 48 h despite autophagy inducing internal signaling being maintained. The relationship between cell growth and autophagy was proved. Increased autophagic flux by rapamycin or LC3B overexpression powerfully reduced cell growth, while autophagy inhibition with shBeclin1 plasmid or chloroquine had no significant effect on regulating cell growth. CONCLUSION: Given these results, maintaining increased autophagic flux was more effective at inhibiting cancer cell progression than inhibition of autophagic flux, which is necessary for the survival of PC3 cells. Autophagic flux should be tightly regulated to maintain metabolic homeostasis for cancer cell growth and survival in PC3 cells and is a suitable target for cancer therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1640-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-07 /pmc/articles/PMC4562121/ /pubmed/26345371 http://dx.doi.org/10.1186/s12885-015-1640-z Text en © Jeon et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Jeon, Jeong Yong Kim, Seung Won Park, Ki Cheong Yun, Mijin The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells |
title | The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells |
title_full | The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells |
title_fullStr | The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells |
title_full_unstemmed | The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells |
title_short | The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells |
title_sort | bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562121/ https://www.ncbi.nlm.nih.gov/pubmed/26345371 http://dx.doi.org/10.1186/s12885-015-1640-z |
work_keys_str_mv | AT jeonjeongyong thebifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells AT kimseungwon thebifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells AT parkkicheong thebifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells AT yunmijin thebifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells AT jeonjeongyong bifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells AT kimseungwon bifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells AT parkkicheong bifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells AT yunmijin bifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells |